Skip to main content

Table 2 Intracellular cytokines—cell prevalence data

From: Cytokine production pattern of T lymphocytes in neonatal arterial ischemic stroke during the first month of life—a case study

% of parent population

 

Moderate HIE

(n = 17)

Severe HIE

(n = 11)

NAIS

(n = 4)

IL-10+ CD8+ / CD8+

6 h

2.75 (1.19–4.12)

4.19 (1.94–6.91)

1.10 (0.40–1.36)

b, p = 0.01

IL-10+ CD4+ / CD4+

24 h

2.88 (1.56–7.03)

4.52 (3.02–6.59)

9.47 (5.10–20.68)

a, p = 0.03

IL-10+ CD8+ / CD8+

72 h

3.51 (1.85–5.12)

5.30 (2.41–6.08)

1.39 (0.52–2.99)

b, p = 0.03

TGF-β + CD49d + CD4+ / CD4+

1 week

10.54 (4.77–14.28)

10.0 (5.46–15.20)

38.00 (14.93–46.78)

a, p = 0.03; b, p = 0.05

TGF-β + CD4+ / CD4+

1 month

3.51 (1.46–4.47)

3.54 (2.47–6.27)

1.30 (0.54–2.49)

b, p = 0.05

IL-17+ CD8+ / CD8+

6 h

3.89 (5.26–14.40)

2.30 (1.73–4.49)

c, p = 0.02

5.04 (4.62–7.68)

b, p = 0.03

IFN-γ + CD4+ / CD4+

72 h

6.40 (3.70–11.80)

6.17 (4.75–13.01)

17.50 (2.74–30.20)

IL-6+ CD8+ /CD8+

72 h

4.37 (3.26–6.29)

5.63 (2.68–8.80)

8.87 (4.75–10.52)

IL-6+ CD8+ /CD8+

1 month

4.02 (2.40–10.74)

3.70 (2.31–6.16)

4.47 (2.88–8.33)

  1. The prevalence of T cells expressing various cytokines are shown as the percentage of the parent population